Caribou Biosciences Inc
CRBUHealthcare|Biotechnology|USA
$1.93
-0.01 (-0.77%)
Tangible Book
$1.05
Upcoming Data Readouts (1)
Dec 2027
Est. completion
P1Relapsed/Refractory Multiple Myeloma
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
NCT05722418n=50